Drug intelligence / Profile preview

FPP004X

Development stage
Unknown
Lead developer
FunPep
Modality
Vaccines & Immunotherapeutics, Peptides
Administration
Subcutaneous (inferred From Typical Administration Route For Peptide Vaccines; Not Explicitly Stated But Likely Based On Modality And Context)
01

Overview

FPP004X is an antibody-inducing peptide vaccine developed by FunPep in collaboration with Osaka University. It is designed to treat allergic diseases—primarily pollinosis (seasonal allergic rhinitis)—by stimulating the body’s immune system to produce antibodies against immunoglobulin E (IgE), a key mediator of allergic reactions. By inducing anti-IgE antibodies, FPP004X aims to provide a sustained therapeutic effect throughout allergy seasons when administered prior to allergen exposure. The drug represents a novel approach for long-lasting management of pollen allergies and is currently in early clinical development[1][3][4][5][6].

Other names
antibody-inducing peptide FunPep/Osaka UniversityIgE antibody target (FunPep/Osaka University)
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on FPP004X.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FPP004X.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call